English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Lipella Pharmaceuticals (LIPO.US)$ Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
23 MINUTES AGO, 5:00 AM EDT
VIA GLOBENEWSWIRE
Patent application covers key technology innovations for delivering therapeutic agents

Proprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship and immunotherapy

Allowance provides broad IP protection for drug-delivery platform and extends market exclusivity for two lead clinical assets currently in Phase 2 trials
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
2
Translate
Report
4744 Views
Comment
Sign in to post a comment